Surgery Partners, Inc. SGRY
Set alert
23.20 USD +0.08 +0.35%
As of Nov 3, 11:23 AM ET
23.17 Day range 23.22
11.41 52-week range 23.37
- YTD
- +50.16%
- 1 year
- +6.91%
- Open
- 23.19
- Prev close
- 23.12
- Mkt cap
- 2.99B
- Vol
- 426.86K
- Avg vol
- 3.40M
- EPS
- -0.69
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 23.17
- High
- 23.22
- Forward P/E
- 111.07
- Beta
- 1.88
- Short ratio
- 6.88
- Inst. own
- 128.71%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 9, 2026
- 50-d avg
- 15.13
- 200-d avg
- 14.63
- 1y target
- 21.70
6M chart
Events in this range
- May 5, 2026Earnings: -0.03; estimate -0.15; surprise 80%
- Aug 10, 2026Earnings: 0.1; estimate 0.05794; surprise 72.59%
- Aug 11, 2026Rating: TD Cowen · Buy → Buy
- Sep 14, 2026Rating: JP Morgan · Neutral → Neutral
- Sep 18, 2026Rating: TD Cowen · Buy → Buy
- Sep 30, 2026Rating: RBC Capital · Outperform → Outperform
- Oct 27, 2026Downgrade: StoneX · Buy → Hold
- Oct 28, 2026Downgrade: UBS · Buy → Neutral
Signals (36)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Oct 26, 2026 | 1 week ago |
| SMA: Bullish | Oct 20, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 16, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 14, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 13, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 12, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 1, 2026 | 1 month ago |
| SMA: Bearish | Sep 29, 2026 | 1 month ago |
| SMA: Bullish | Sep 28, 2026 | 1 month ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| SMA: Bullish | Sep 22, 2026 | 1 month ago |
| SMA: Bullish | Sep 22, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 22, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 17, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 1, 2026 | 2 months ago |
| SMA: Bearish | Aug 17, 2026 | 2 months ago |
| SMA: Bearish | Aug 11, 2026 | 2 months ago |
| SMA: Bullish | Aug 7, 2026 | 2 months ago |
| SMA: Bearish | Aug 6, 2026 | 2 months ago |
Newest 20 of 36.
Analyst view
Consensus: buy
Buy
Price target (mean) 21.70 -6.5% downside
Now 23.20
- Target (low)
- 19.00
- Target (mean)
- 21.70
- Target (high)
- 23.50
Ratings (0m) 7 2 buy · 5 hold · 0 sell
- Strong buy0
- Buy2
- Hold5
- Sell0
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 12
- 2 months ago 12
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.12467 | 0.07 – 0.20 | 0.13 | -4.1% | 814.70M | -0.8% | 5 |
| Next quarter | 0.15486 | 0.02429 – 0.33 | 0.12 | +29.0% | 680.50M | -23.1% | 5 |
| Current year | 0.35596 | 0.21981 – 0.60 | 0.47 | -24.3% | 3.15B | -4.7% | 5 |
| Next year | 0.20815 | 0.03 – 0.43 | 0.35596 | -41.5% | 2.80B | -11.2% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 28, 2026 | UBS | Downgrade | Buy | Neutral |
| Oct 27, 2026 | StoneX | Downgrade | Buy | Hold |
| Sep 30, 2026 | RBC Capital | Reiterated | Outperform | Outperform |
| Sep 18, 2026 | TD Cowen | Reiterated | Buy | Buy |
| Sep 14, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Aug 11, 2026 | TD Cowen | Maintained | Buy | Buy |
| Aug 11, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 11, 2026 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Mar 5, 2026 | TD Cowen | Maintained | Buy | Buy |
| Mar 5, 2026 | UBS | Maintained | Buy | Buy |
| Mar 5, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Mar 4, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Mar 3, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Dec 18, 2025 | Mizuho | Maintained | Outperform | Outperform |
| Nov 24, 2025 | JP Morgan | Maintained | Neutral | Neutral |
| Nov 21, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Nov 17, 2025 | Mizuho | Maintained | Outperform | Outperform |
| Nov 13, 2025 | UBS | Maintained | Buy | Buy |
| Nov 11, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Nov 11, 2025 | Benchmark | Maintained | Buy | Buy |
| Oct 7, 2025 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| May 27, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Apr 21, 2025 | Benchmark | Reiterated | Buy | Buy |
| Mar 25, 2025 | RBC Capital | Reiterated | Outperform | Outperform |
| Mar 11, 2025 | Macquarie | Maintained | Outperform | Outperform |
| Dec 3, 2024 | JP Morgan | Maintained | Neutral | Neutral |
| Nov 20, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Nov 19, 2024 | Macquarie | Maintained | Outperform | Outperform |
| Nov 13, 2024 | Macquarie | Maintained | Outperform | Outperform |
| Nov 4, 2024 | Macquarie | Maintained | Outperform | Outperform |